Cargando…
DNA topoisomerase IIα and mitosin expression predict meningioma recurrence better than histopathological grade and MIB-1 after initial surgery
BACKGROUND: The 2016 WHO histopathological grade or conventional biomarker MIB-1 is insufficient for predicting meningioma recurrence after initial treatment and alternative strategies are required. In this study, we investigated whether DNA topoisomerase IIα and/or mitosin expression can predict tu...
Autores principales: | Winther, Theo L., Torp, Sverre H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354255/ https://www.ncbi.nlm.nih.gov/pubmed/28301542 http://dx.doi.org/10.1371/journal.pone.0172316 |
Ejemplares similares
-
Evaluation of the proliferation markers Ki-67/MIB-1, mitosin, survivin, pHH3, and DNA topoisomerase IIα in human anaplastic astrocytomas - an immunohistochemical study
por: Habberstad, Andreas H, et al.
Publicado: (2011) -
WHO Grade I Meningioma Recurrence: Identifying High Risk Patients Using Histopathological Features and the MIB-1 Index
por: Haddad, Alexander F., et al.
Publicado: (2020) -
The anti-apoptotic protein survivin can improve the prognostication of meningioma patients
por: Winther, Theo L., et al.
Publicado: (2017) -
Prognostic value of ErbB2/HER2 in human meningiomas
por: Arnli, Magnus B., et al.
Publicado: (2018) -
Advances in Research on Human Meningiomas
por: Torp, Sverre Helge, et al.
Publicado: (2020)